N. Goldstein

发表

Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study

V. Bockstal, Benoît Callendret, Auguste Gaddah, 2020, The Journal of infectious diseases.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

S. Lees, D. Watson-Jones, B. Lowe, 2021, The Lancet. Infectious diseases.

Oral abstracts 1: SpondyloarthropathiesO1. Detecting axial spondyloarthritis amongst primary care back pain referrals

C. Cooper, D. Gladman, W. Tillett, 2012 .

BSR AND BHPR ORAL PRESENTATION OF ABSTRACTS ORAL ABSTRACTS 1: SPONDYLOARTHROPATHIES

D. Gladman, R. Landewé, P. Emery, 2012 .

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study

M. McElrath, S. D. De Rosa, M. Pau, 2022, PloS one.

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.

Y. Lévy, A. Pollard, J. Lelièvre, 2020, The Lancet. Infectious diseases.

Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

E. Keystone, B. Hsu, J. Braun, 2016, The Journal of Rheumatology.

Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)

D. Gladman, D. M. van der Heijde, P. Mease, 2014, Annals of the rheumatic diseases.

LONG-TERM RADIOGRAPHIC OUTCOME IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB : 104 WEEK RESULTS FROM THE GO-REVEAL STUDY

D. Gladman, P. Mease, A. Kavanaugh, 2012 .

Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen

V. Bockstal, Auguste Gaddah, M. Douoguih, 2021, npj Vaccines.

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

S. Lees, D. Watson-Jones, B. Lowe, 2021, The Lancet. Infectious diseases.

Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.

D. M. van der Heijde, H. Houben, R. Landewé, 2008, Arthritis and rheumatism.

Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.

B. Dijkmans, P. Geusens, A. Deodhar, 2008, Arthritis and rheumatism.

Vena cava filter fracture with migration to the pulmonary artery.

D. Hill, E. Kuo, N. Goldstein, 2013, The Annals of thoracic surgery.

Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen

V. Bockstal, Auguste Gaddah, M. Douoguih, 2021, NPJ vaccines.

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

E. Keystone, A. Kavanaugh, B. Hsu, 2013, Annals of the rheumatic diseases.

Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults

C. Truyers, M. Douoguih, N. Goldstein, 2016 .

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

E. Keystone, A. Kavanaugh, B. Hsu, 2013, Annals of the rheumatic diseases.